SCHEMBL14738699

SCHEMBL14738699

N=C(S)N1CCC=N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25405952 0.70 DPP4 (0.37)
SCHEMBL13324943 0.60 ITGB1 (0.32)
SCHEMBL25395345 0.55
SCHEMBL18654409 0.51
SCHEMBL12116389 0.51
SCHEMBL10764949 0.40
SCHEMBL6213386 0.40
Thiourea SCHEMBL50650 0.39
Thiourea SCHEMBL1395770 0.39 NOS2 (0.36)
SCHEMBL15703034 0.39

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2528900-B1 SYNTHESIS OF SUBSTITUTED PYRAZOLINE CARBOXAMIDINE DERIVATIVES ABBVIE BAHAMAS LTD (BS) 2014-06-11 EP claimed
US-20130060041-A1 SYNTHESIS OF SUBSTITUTED PYRAZOLINE CARBOXAMIDINE DERIVATIVES ABBOTT HOSPITALS LIMITED (BS) 2013-03-07 US claimed
US-20250026723-A1 Cannabinoid Receptor Modulating Compounds THE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN (US) 2025-01-23 US disclosed
US-9422244-B2 Synthesis of substituted pyrazoline carboxamidine derivatives ABBVIE BAHAMAS LTD. (BS) 2016-08-23 US disclosed
EP-2528900-B1 SYNTHESIS OF SUBSTITUTED PYRAZOLINE CARBOXAMIDINE DERIVATIVES ABBVIE BAHAMAS LTD (BS) 2014-06-11 EP disclosed
US-20130060041-A1 SYNTHESIS OF SUBSTITUTED PYRAZOLINE CARBOXAMIDINE DERIVATIVES ABBOTT HOSPITALS LIMITED (BS) 2013-03-07 US disclosed